Futibatinib is an FGFR inhibitor. It’s made specifically for cholangiocarcinoma patients who have FGFR2 fusions. It blocksFGFR signaling to work its magic.
You can get these tablets in 4 mg strength. The usual dose is 20 mg every day. The tablets come in bottles with 28 tablets in each.
